Ninety-five percent of finance chiefs have adjusted their pricing strategies in the past six months, a Deloitte survey finds.

Since reaching a peak of over 9% in 2022, inflation appears to finally be cooling for the average consumer. As costs rose over the last two years, companies across the globe have worked to protect ...

As the technology continues to evolve, the key differentiator will be how companies use these tools to create value for both themselves and their customers. The Fast Company Executive Board is a ...

Feeling like walking a tightrope with pricing strategies? You're not alone. Original equipment manufacturers (OEMs) in the heavy equipment industry face myriad of challenges when devising pricing ...

Pricing expert Rafi Mohammed warns against hasty changes to keep customers. Rafi Mohammed, founder of the consulting firm Culture of Profit, says a crisis or recession is not the time to panic and ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Retail pricing strategies have come a long way thanks to AI and ...

LONDON--(BUSINESS WIRE)--Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest article on reasons why businesses must update their ...

Opinions expressed by Entrepreneur contributors are their own. Far too often, startups treat pricing as an afterthought. Upon going to market, founders seldom blame pricing should their company fail ...

A conversation with pricing expert Rafi Mohammed on when and how to change prices in response to Covid-19. Rafi Mohammed, founder of the consulting firm Culture of Profit, says a crisis or recession ...

Panelists discuss how biosimilar manufacturers offer both high-wholesale acquisition cost (WAC) and low-WAC product versions to navigate complex reimbursement landscapes, sharing their experiences ...

The panel discusses the economic impact biosimilars have across different patient types. What economic impacts do biosimilars have in different delivery channels (inpatient, self-administered ...